Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 07/12/19941 min de lecture
21 CFR Parts 864, 866, 868, 870, 872, 874, 876, 878, 880, 882, 886, 888, 890, and 892
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is exempting 148 generic types of class I devices from the requirement of premarket notification, with limitations. For the exempted devices, FDA has determined that manufacturers' submissions of premarket notifications are unnecessary for the protection of the public health and that the agency's review of such submissions will not advance its public health mission. The exemptions allow the agency to make better use of its resources and thus better serve the public.
Langue originale de la source: Federal Register — Health and Human ServicesOuvrir le communiqué original →